Literature DB >> 25551239

Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES).

Chad D Rethorst1, Ira Bernstein, Madhukar H Trivedi.   

Abstract

OBJECTIVE: To describe the rates of elevated inflammation, obesity, and metabolic syndrome (MetS) within a large cohort of individuals with depression and to examine the interrelationships of inflammation and MetS in depressed individuals.
METHOD: Analyses were conducted on study participants from the 2009-2010 National Health and Nutrition Examination Survey (NHANES) with Patient Health Questionnaire (PHQ-9) depression scores ≥ 10 to (1) examine the relationship of inflammation (C-reactive protein; CRP) with demographic and clinical characteristics and (2) examine the prevalence of MetS criteria within CRP groups.
RESULTS: 5,579 participants provided PHQ-9 data; of those, 606 had PHQ-9 scores ≥ 10 and were included in further analysis. Of the 606 depressed participants, 585 participants had valid CRP data; 275 participants (47.01%) had CRP levels ≥ 3.0 mg/L, while 170 (29.06%) had CRP levels ≥ 5.0 mg/L. Elevated inflammation was significantly correlated with body weight, waist circumference, body mass index, insulin, 2-hour glucose tolerance, and self-report general health (P values < .05). 112 subjects (41.18%) met American Heart Association/National Heart, Lung, and Blood Institute criteria for MetS. Those with elevated CRP were more likely to meet criteria for MetS (odds ratios of 2.81 for those with CRP levels ≥ 3.0 mg/L and 1.94 for those with CRP levels ≥ 5.0 mg/L).
CONCLUSIONS: Over 29% of depressed individuals had elevated levels of CRP, and 41% met criteria for MetS. Individuals with elevated inflammation are more likely to be obese and meet criteria for MetS. These results highlight the significant inflammatory and metabolic burden of individuals with depression. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25551239      PMCID: PMC4309548          DOI: 10.4088/JCP.14m09009

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  36 in total

1.  Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults.

Authors:  Earl S Ford
Journal:  Epidemiology       Date:  2002-09       Impact factor: 4.822

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  Cytokine production and treatment response in major depressive disorder.

Authors:  S Lanquillon; J C Krieg; U Bening-Abu-Shach; H Vedder
Journal:  Neuropsychopharmacology       Date:  2000-04       Impact factor: 7.853

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  Effects of serum Brain Derived Neurotrophic Factor on exercise augmentation treatment of depression.

Authors:  Marisa S P Toups; Tracy L Greer; Benji T Kurian; Bruce D Grannemann; Thomas J Carmody; Ryan Huebinger; Chad Rethorst; Madhukar H Trivedi
Journal:  J Psychiatr Res       Date:  2011-10       Impact factor: 4.791

6.  Using epidemiological data to model efficiency in reducing the burden of depression*

Authors:  Gavin Andrews; Kristy Sanderson; Justine Corry; Helen M. Lapsley
Journal:  J Ment Health Policy Econ       Date:  2000-12-01

Review 7.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

8.  Depressive symptoms and metabolic syndrome: is inflammation the underlying link?

Authors:  Lucile Capuron; Shaoyong Su; Andrew H Miller; J Douglas Bremner; Jack Goldberg; Gerald J Vogt; Carisa Maisano; Linda Jones; Nancy V Murrah; Viola Vaccarino
Journal:  Biol Psychiatry       Date:  2008-07-02       Impact factor: 13.382

9.  Atypical depressive symptoms and obesity in a national sample of older adults with major depressive disorder.

Authors:  Kee-Lee Chou; Kar-Ming Yu
Journal:  Depress Anxiety       Date:  2013-04-03       Impact factor: 6.505

10.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

Authors:  Charles L Raison; Robin E Rutherford; Bobbi J Woolwine; Chen Shuo; Pamela Schettler; Daniel F Drake; Ebrahim Haroon; Andrew H Miller
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

View more
  56 in total

1.  Treating major depressive episodes with antidepressants can induce or worsen metabolic syndrome: results of the METADAP cohort.

Authors:  Emmanuelle Corruble; Khalil El Asmar; Severine Trabado; Céline Verstuyft; Bruno Falissard; Romain Colle; Anne-Cécile Petit; Florence Gressier; Sylvie Brailly-Tabard; Florian Ferreri; Jean-Pierre Lépine; Emmanuel Haffen; Mircea Polosan; Céline Bourrier; Gabriel Perlemuter; Philippe Chanson; Bruno Fève; Laurent Becquemont
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

Review 2.  Inflammation: depression fans the flames and feasts on the heat.

Authors:  Janice K Kiecolt-Glaser; Heather M Derry; Christopher P Fagundes
Journal:  Am J Psychiatry       Date:  2015-09-11       Impact factor: 18.112

3.  Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.

Authors:  Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Tracy Greer; Bruce Grannemann; Abigail Soyombo; Taryn L Mayes; A John Rush; Madhukar H Trivedi
Journal:  Psychoneuroendocrinology       Date:  2017-01-24       Impact factor: 4.905

4.  Independent and joint association of obesity and metabolic syndrome with depression and inflammation.

Authors:  Kasra Moazzami; Bruno B Lima; Samaah Sullivan; Amit Shah; J Douglas Bremner; Viola Vaccarino
Journal:  Health Psychol       Date:  2019-05-23       Impact factor: 4.267

Review 5.  Microbiome and Mental Health, Specifically as It Relates to Adolescents.

Authors:  Deborah R Simkin
Journal:  Curr Psychiatry Rep       Date:  2019-09-02       Impact factor: 5.285

6.  Previous Mental Disorders and Subsequent Onset of Chronic Back or Neck Pain: Findings From 19 Countries.

Authors:  Maria Carmen Viana; Carmen C W Lim; Flavia Garcia Pereira; Sergio Aguilar-Gaxiola; Jordi Alonso; Ronny Bruffaerts; Peter de Jonge; Jose Miguel Caldas-de-Almeida; Siobhan O'Neill; Dan J Stein; Ali Al-Hamzawi; Corina Benjet; Graça Cardoso; Silvia Florescu; Giovanni de Girolamo; Josep Maria Haro; Chiyi Hu; Viviane Kovess-Masfety; Daphna Levinson; Marina Piazza; José Posada-Villa; Daniel Rabczenko; Ronald C Kessler; Kate M Scott
Journal:  J Pain       Date:  2017-10-12       Impact factor: 5.820

7.  Transcriptomic predictors of inflammation-induced depressed mood.

Authors:  Joshua Hyong-Jin Cho; Michael R Irwin; Naomi I Eisenberger; Donald M Lamkin; Steve W Cole
Journal:  Neuropsychopharmacology       Date:  2019-01-14       Impact factor: 7.853

Review 8.  Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment.

Authors:  Seong Lin Teoh; Srijit Das
Journal:  Tumour Biol       Date:  2016-09-14

9.  A Randomized Controlled Trial of a Patient-Centered Approach to Improve Screening for the Metabolic Side Effects of Antipsychotic Medications.

Authors:  Julie Kreyenbuhl; Lisa B Dixon; Clayton H Brown; Deborah R Medoff; Elizabeth A Klingaman; Li Juan Fang; Stephanie Tapscott; Mary Brighid Walsh
Journal:  Community Ment Health J       Date:  2016-04-09

10.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

Authors:  Davy Vancampfort; Brendon Stubbs; Alex J Mitchell; Marc De Hert; Martien Wampers; Philip B Ward; Simon Rosenbaum; Christoph U Correll
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.